HopeStage
Back to all studies
RecruitingNCT06247839

Single-dose psilocybin and rumination in people with depression

About this titleRead the official source — NCT06247839
Medication studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.

What will I do during this study?

You receive a single 25 mg dose of psilocybin in an open-label fMRI study. The team measures rumination and brain activity around dosing, then follows selected outcomes at 3, 6, 9 and 12 weeks.

Listed locations
CharlestownSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 10, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
20
Sponsor
Sharmin Ghaznavi
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT06247839
Official title
Show the full official title

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

Recruitment & locations

Currently recruiting

Charlestown

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sharmin Ghaznavi.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies